Primary percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction complicated by «no-reflow» phenomenon

Cover Page


Cite item

Full Text

Abstract

Aim. To study the association of «no-reflow» phenomenon incidence and the method of primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction, and to determine the optimal tactics for primary coronary intervention.

Methods. A retrospective analysis of 1339 cases of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction performed in the period from January 2008 to June 2013 was executed. Depending on surgery method, all the patients were allocated to four groups: first group - direct stenting (n=483); second group - thromboaspiration before stenting (n=142); third group - balloon angioplasty and stenting using a small-diameter balloon ≤2.0 mm (n=491); fourth group - balloon angioplasty and stenting using a small-diameter balloon and subsequent use of medium and large-diameter balloons ≥2.0 mm (n=223).

Results. «No-reflow» phenomenon was observed in 164 (12.2%) of cases, incliding 34 (7.0%) cases in the first group, 12 (8.4%) cases in the second group, 53 (10.8%) cases in the third group, and with the majority of cases seen in the fourth group - 65 (29.1%). At primary percutaneous coronary intervention, the following incidence of «no-reflow» phenomenon was observed depending on the infarct-related artery: left anterior descending artery - 85 cases (51.82% of the total number), right coronary artery - 51 (31.09%) cases, circumflex artery - 28 (17.07%) cases, and diagonal branch - 1 (0.6%) case.

Conclusion. In primary percutaneous coronary intervention with direct stenting and thromboaspiration before stenting, the incidence of «no-reflow» phenomenon is significantly lower. Patients who undergo primary percutaneous coronary intervention preceded by repeated balloon angioplasty using medium and large-diameter balloons are at higher risk for «no-reflow» phenomenon.

About the authors

M M Iskhakov

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Author for correspondence.
Email: marssurgeon@gmail.com

R R Sayfullin

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Email: marssurgeon@gmail.com

I R Yagafarov

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Email: marssurgeon@gmail.com

M G Khatypov

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Email: marssurgeon@gmail.com

N V Gazizov

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia

Email: marssurgeon@gmail.com

L A Nugaybekova

Kazan State Medical Academy, Kazan, Russia

Email: marssurgeon@gmail.com

R G Sayfutdinov

Medical and sanitary unit of JSC «Tatneft» and the city of Almetyevsk, Almetyevsk, Russia; Kazan State Medical Academy, Kazan, Russia

Email: marssurgeon@gmail.com

References

  1. Коваль М. Феномен «no-reflow» - ложка дёгтя в бочке меда реваскуляризации // Medicine Review. - 2008. - №5 (05). - С. 32-36.
  2. Копица Н.П., Вишневская И.Р. Феномен «no-reflow» - современный взгляд на проблему. Место блокаторов гликопротеиновых IIb/IIIa рецепторов в предупреждении данного состояния // Вестн. Харьков. нац. ун-та им. В.Н. Каразина. Серия «Медицина». - 2011. - №22 (975). - С. 17-21.
  3. Крыжановская С.А., Матюшин Г.В., Протопопов А.В. Феномен «no-reflow»: частота, причины возникновения, клинические проявления - http://likeinvest.org.sworld.com.ua/konfer27/126.pdf (дата обращения: 02.04.15).
  4. Мовсесянц М.Ю., Киселёв Д.Г., Миронков А.Б. и др. Профилактика и лечение обструкции микрососудов при выполнении чрескожного коронарного вмешательства // Кардиол. и сердечно-сосудист. хир. - 2012. - Т. 5, №3. - С. 30-37.
  5. Пархоменко А.Н. Феномен невосстановленного кровотока у больных с острым коронарным синдромом и возможные пути улучшения тканевой перфузии // Україн. кардіол. ж. - 2007. - №5. - С. 17-25.
  6. Сидоренко Г.И., Островский Ю.П. Феномен «невозобновления кровотока» (no-reflow) и его клиническое значение // Кардиология. - 2002. - №5. - С. 74-80.
  7. De Lemos J.A., Antman E.M., Giugliano R.P. et al. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy: Thrombolysis in Myocardial Infarction (TIMI). 14 investigators // Am. J. Cardiol. - 2000. - Vol. 85. - P. 299-304. http://dx.doi.org/10.1016/S0002-9149(99)00736-5
  8. Grabern P.A., Choi J.W. Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction // JACC. - 2008. - Vol. 51, N 5. - P. 566-568. http://dx.doi.org/10.1016/j.jacc.2007.10.024
  9. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction // Nat. Clin. Pract. Cardiovasc. Med. - 2006. - Vol. 3. - P. 499-506. http://dx.doi.org/10.1038/ncpcardio0632
  10. Rezkalla S.H., Kloner R.A. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory // Catheter Cardiovasc. Interv. - 2008. - Vol. 72, N 7. - P. 950-957. http://dx.doi.org/10.1002/ccd.21715
  11. Van de Werf F., Bax J., Betriu A. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology // Eur. Heart J. - 2008. - Vol. 29. - P. 2909-2945. http://dx.doi.org/10.1093/eurheartj/ehn416
  12. Van Gaal W.J., Banning A.P. Percutaneous coronary intervention and the no-reflow phenomenon // Expert Rev. Cardiovasc. Ther. - 2007. - Vol. 5, N 4. - P. 715-731. http://dx.doi.org/10.1586/14779072.5.4.715

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2015 Iskhakov M.M., Sayfullin R.R., Yagafarov I.R., Khatypov M.G., Gazizov N.V., Nugaybekova L.A., Sayfutdinov R.G.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies